Combined inguinal and pelvic lymph node dissection for stage III melanoma.
Identifieur interne : 004B70 ( PubMed/Corpus ); précédent : 004B69; suivant : 004B71Combined inguinal and pelvic lymph node dissection for stage III melanoma.
Auteurs : T M Hughes ; J M ThomasSource :
- The British journal of surgery [ 0007-1323 ] ; 1999.
English descriptors
- KwdEn :
- MESH :
- methods : Lymph Node Excision.
- pathology : Skin Neoplasms.
- secondary : Melanoma.
- surgery : Melanoma, Skin Neoplasms.
- Humans, Inguinal Canal, Lymphatic Metastasis, Pelvis, Risk Factors, Survival Analysis.
Abstract
The incidence of melanoma is increasing in the UK and a significant number of patients are still presenting with primary lesions of poor prognosis. As a consequence there is likely to be an increasing number of patients with lymph node metastases for whom the appropriate extent of groin dissection remains controversial. This review summarizes the evidence to enable surgeons to make an informed decision about the management of patients with melanoma metastases to the groin lymph nodes.
DOI: 10.1046/j.1365-2168.1999.01316.x
PubMed: 10594495
Links to Exploration step
pubmed:10594495Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Combined inguinal and pelvic lymph node dissection for stage III melanoma.</title>
<author><name sortKey="Hughes, T M" sort="Hughes, T M" uniqKey="Hughes T" first="T M" last="Hughes">T M Hughes</name>
<affiliation><nlm:affiliation>Melanoma and Sarcoma Unit, Royal Marsden Hospital NHS Trust, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Thomas, J M" sort="Thomas, J M" uniqKey="Thomas J" first="J M" last="Thomas">J M Thomas</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1999">1999</date>
<idno type="RBID">pubmed:10594495</idno>
<idno type="pmid">10594495</idno>
<idno type="doi">10.1046/j.1365-2168.1999.01316.x</idno>
<idno type="wicri:Area/PubMed/Corpus">004B70</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004B70</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Combined inguinal and pelvic lymph node dissection for stage III melanoma.</title>
<author><name sortKey="Hughes, T M" sort="Hughes, T M" uniqKey="Hughes T" first="T M" last="Hughes">T M Hughes</name>
<affiliation><nlm:affiliation>Melanoma and Sarcoma Unit, Royal Marsden Hospital NHS Trust, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Thomas, J M" sort="Thomas, J M" uniqKey="Thomas J" first="J M" last="Thomas">J M Thomas</name>
</author>
</analytic>
<series><title level="j">The British journal of surgery</title>
<idno type="ISSN">0007-1323</idno>
<imprint><date when="1999" type="published">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term>
<term>Inguinal Canal</term>
<term>Lymph Node Excision (methods)</term>
<term>Lymphatic Metastasis</term>
<term>Melanoma (secondary)</term>
<term>Melanoma (surgery)</term>
<term>Pelvis</term>
<term>Risk Factors</term>
<term>Skin Neoplasms (pathology)</term>
<term>Skin Neoplasms (surgery)</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Melanoma</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Inguinal Canal</term>
<term>Lymphatic Metastasis</term>
<term>Pelvis</term>
<term>Risk Factors</term>
<term>Survival Analysis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The incidence of melanoma is increasing in the UK and a significant number of patients are still presenting with primary lesions of poor prognosis. As a consequence there is likely to be an increasing number of patients with lymph node metastases for whom the appropriate extent of groin dissection remains controversial. This review summarizes the evidence to enable surgeons to make an informed decision about the management of patients with melanoma metastases to the groin lymph nodes.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10594495</PMID>
<DateCreated><Year>2000</Year>
<Month>01</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted><Year>2000</Year>
<Month>01</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0007-1323</ISSN>
<JournalIssue CitedMedium="Print"><Volume>86</Volume>
<Issue>12</Issue>
<PubDate><Year>1999</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>The British journal of surgery</Title>
<ISOAbbreviation>Br J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Combined inguinal and pelvic lymph node dissection for stage III melanoma.</ArticleTitle>
<Pagination><MedlinePgn>1493-8</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The incidence of melanoma is increasing in the UK and a significant number of patients are still presenting with primary lesions of poor prognosis. As a consequence there is likely to be an increasing number of patients with lymph node metastases for whom the appropriate extent of groin dissection remains controversial. This review summarizes the evidence to enable surgeons to make an informed decision about the management of patients with melanoma metastases to the groin lymph nodes.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A Medline search was performed to identify all English language articles about melanoma containing the words lymphadenectomy, lymph nodes, inguinal or lymphoedema. Eighty-seven relevant articles were selected from 3904 abstracts retrieved; 34 were related directly to the aim of this review.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There are no randomized controlled trials comparing the outcome of combined inguinal and pelvic lymph node dissection (CLND) and superficial inguinal lymph node dissection (SLND). Excision of pelvic lymph node metastases is reported to yield a 5-year survival rate of 0-35 per cent. Recurrence within the pelvis occurs in 9-18 per cent of patients after SLND and in less than 5 per cent after CLND. Morbidity following either CLND or SLND is poorly reported. Major long-term lymphoedema limiting patient activity affects 6-20 per cent of patients after groin dissection. Cloquet's node was demonstrated in one study to be a useful predictor of pelvic lymph node involvement. Patients may be selected for pelvic node dissection on the basis of clinical findings, the results of pelvic computed tomography and the status of Cloquet's node.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The controversy surrounding the appropriate management of cytologically positive inguinal nodes in melanoma can be resolved only by a prospective randomized trial comparing CLND with SLND. Morbidity and local disease control must be measured as outcomes in addition to disease-free and overall survival.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hughes</LastName>
<ForeName>T M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo><Affiliation>Melanoma and Sarcoma Unit, Royal Marsden Hospital NHS Trust, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Thomas</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Br J Surg</MedlineTA>
<NlmUniqueID>0372553</NlmUniqueID>
<ISSNLinking>0007-1323</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007264" MajorTopicYN="N">Inguinal Canal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName>
<QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010388" MajorTopicYN="N">Pelvis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>34</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year>
<Month>12</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1999</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1999</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">10594495</ArticleId>
<ArticleId IdType="pii">bjs1316</ArticleId>
<ArticleId IdType="doi">10.1046/j.1365-2168.1999.01316.x</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004B70 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 004B70 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:10594495 |texte= Combined inguinal and pelvic lymph node dissection for stage III melanoma. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:10594495" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |